Rekomendacje dotyczące ograniczania przenoszenia wirusa Zachodniego Nilu (WNV) przez transfuzje krwi oraz jej składników na terenie Polski
Streszczenie
Od wielu lat wirus Zachodniego Nilu znajduje się w centrum zainteresowania transfuzjologów ze względu na udokumentowane przenoszenie przez transfuzje krwi oraz jej składników. W ostatnich latach obserwuje się okresowe zwiększanie liczby zakażeń w Europie (2018 r.) oraz ogniska zakażeń wśród zwierząt oraz u ludzi na terenach, na których dotychczas obecność wirusa nie była obserwowana. W niniejszej pracy dokonano aktualizacji danych dotyczących biologii oraz epidemiologii wirusa Zachodniego Nilu prezentowanych w publikacji „Journal of Transfusion Medicine” [1] oraz przedstawiono propozycje postępowania mającego na celu zapobieganiu przenoszenia wirusa przez transfuzje na wypadek pojawienia się zakażeń ludzi na terenie Polski. Zalecenia krajowe powstały na podstawie rekomendacji międzynarodowych, w wyniku współpracy transfuzjologów ze specjalistami chorób zakaźnych oraz z ośrodkami naukowymi monitorującymi epidemiologie wirusa.
Słowa kluczowe: wirus Zachodniego Niludawcy krwibezpieczeństwo transfuzjiPolskazalecenia
Referencje
- Tkaczuk K, Sulkowska E, Lachert E, et al. Wirus Zachodniego Nilu a bezpieczeństwo przetoczeń krwi i jej składników. Journal of Tranfusion Medicine 2013, tom 6, nr. ; 3: 1–XX.
- Smithburn KC, Hughes TP, Burke AW, et al. A Neurotropic Virus Isolated from the Blood of a Native of Uganda 1. Am. J. Trop. Med. Hyg. 1940; s1-20(4): 471–492.
- Martin DA, Biggerstaff BJ, Allen B, et al. Use of immunoglobulin m cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States. Clin Diagn Lab Immunol. 2002; 9(3): 544–549.
- Knap JP, Kubica-Biernat B. [Did West Nile Fever (WNF) appear in Poland? Position of the Expect Committee appointed by the Chief Sanitary Inspector]. Przegl Epidemiol. 2003; 57(3): 399–404.
- De Filette M, Ulbert S, Diamond M, et al. Recent progress in West Nile virus diagnosis and vaccination. Vet Res. 2012; 43: 16.
- May FJ, Davis CT, Tesh RB, et al. Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas. J Virol. 2011; 85(6): 2964–2974.
- Mentoor JLD, Lubisi AB, Gerdes T, et al. Full-Genome Sequence of a Neuroinvasive West Nile Virus Lineage 2 Strain from a Fatal Horse Infection in South Africa. Genome Announc. 2016; 4(4).
- McMullen AR, Albayrak H, May FJ, et al. Molecular evolution of lineage 2 West Nile virus. J Gen Virol. 2013; 94(Pt 2): 318–325.
- Weissenböck H, Hubálek Z, Bakonyi T, et al. Novel flavivirus or new lineage of West Nile virus, central Europe. Emerg Infect Dis. 2005; 11(2): 225–231.
- Rudolf I, Bakonyi T, Sebesta O, et al. West Nile virus lineage 2 isolated from Culex modestus mosquitoes in the Czech Republic, 2013: expansion of the European WNV endemic area to the North? Euro Surveill. 2014; 19(31): 2–5.
- Pesko KN, Ebel GD. West Nile virus population genetics and evolution. Infect Genet Evol. 2012; 12(2): 181–190.
- Chancey C, Grinev A, Volkova E, et al. The global ecology and epidemiology of West Nile virus. Biomed Res Int. 2015; 2015: 376230.
- Bondre VP, Jadi RS, Mishra AC, et al. West Nile virus isolates from India: evidence for a distinct genetic lineage. J Gen Virol. 2007; 88(Pt 3): 875–884.
- Prow NA, Hewlett EK, Faddy HM, et al. The Australian Public is Still Vulnerable to Emerging Virulent Strains of West Nile Virus. Front Public Health. 2014; 2: 146.
- Moureau G, Cook S, Lemey P, et al. New insights into flavivirus evolution, taxonomy and biogeographic history, extended by analysis of canonical and alternative coding sequences. PLoS One. 2015; 10(2): e0117849.
- Kondrusik M, Ferenczi E, Zajkowska J, et al. [The evaluation of serum presence of antibodies reacting with West Nile Fever virus (WNV) antigens among inhabitants from Podlaskie and Swietokrzyskie region]. Przegl Epidemiol. 2007; 61(2): 409–416.
- Samorek-Salamonowicz E. Wirus Zachodniego Nilu — zagrożenie dla zdrowia publicznego. W: Niczyporuk J.S. (red.). Medycyna Weterynaryjna 2008: 1368–1370.
- Kilpatrick A, LaDeau S, Marra P. ECOLOGY OF WEST NILE VIRUS TRANSMISSION AND ITS IMPACT ON BIRDS IN THE WESTERN HEMISPHERE. The Auk. 2007; 124(4): 1121.
- Samorek-Salamonowicz E, Niczyporuk JS. West Nile virus other emerging threats to public health. Postępy Mikrobiologii. 2010; 49: 187–90.
- Strauss JH, Strauss EG. Viruses and Human Disease, wyd. 2, Academic Press. 2007; 3: 118.
- Arjona A, Wang P, Montgomery RR, et al. Innate immune control of West Nile virus infection. Cell Microbiol. 2011; 13(11): 1648–1658.
- Colpitts TM, Conway MJ, Montgomery RR, et al. West Nile Virus: biology, transmission, and human infection. Clin Microbiol Rev. 2012; 25(4): 635–648.
- Konrad SK, Miller SN. Application of a degree-day model of West Nile virus transmission risk to the East Coast of the United States of America. Geospat Health. 2012; 7(1): 15–20.
- West Nile Fever [monograph on the internet]. Epi-News, National surveillance of communicable diseases: Statens Serum Institut; 2003. Available from: http://www ssi dk/English/News/EPI-NEWS/~/media/Indhold/EN%20-%20engelsk/EPI-NEWS/2003/pdf/EPI-NEWS%20-%202003%20-%20No. ; 204: ashx.
- Kilpatrick AM, Meola MA, Moudy RM, et al. Temperature, viral genetics, and the transmission of West Nile virus by Culex pipiens mosquitoes. PLoS Pathog. 2008; 4(6): e1000092.
- West Nile Virus MONITOR Surveillance Maps- Clinical Cases and Asymptomatic Infections Canada, October 27, 2012, Public Health Agency of Canada, http://www.phac-aspc.gc.ca/wnv-vwn/map-carte/map-carte-surv2012-eng.php.
- Semenza JC, Tran A, Espinosa L, et al. Climate change projections of West Nile virus infections in Europe: implications for blood safety practices. Environ Health. 2016; 15 Suppl 1: 28.
- Pridjian G, Sirois PA, McRae S, et al. Prospective study of pregnancy and newborn outcomes in mothers with West nile illness during pregnancy. Birth Defects Res A Clin Mol Teratol. 2016; 106(8): 716–723.
- Hermanowska-Szpakowicz T, Grygorczuk S, Kondrusik M, et al. [Infections caused by West Nile virus]. Przegl Epidemiol. 2006; 60(1): 93–98.
- West Nile virus infection - Annual Epidemiological Report for 2018, https://www.ecdc.europa.eu/en/publications-data/west-nile-virus-infection-annual-epidemiological-report-2018.
- Epidemiological update: West Nile virus transmission season in Europe, 2019, https://www.ecdc.europa.eu/en/news-events/epidemiological-update-west-nile-virus-transmission-season-europe-2019.
- Juricová Z, Pinowski J, Literák I, et al. Antibodies to alphavirus, flavivirus, and bunyavirus arboviruses in house sparrows (Passer domesticus) and tree sparrows (P. montanus) in Poland. Avian Dis. 1998; 42(1): 182–185.
- Hubálek Z, Wegner E, Halouzka J, et al. Serologic survey of potential vertebrate hosts for West Nile virus in Poland. Viral Immunol. 2008; 21(2): 247–253.
- Niczyporuk JS. E. Samorek-Salamonowicz. Study of the NRT-PCR method for the detection of the West Nile Virus. Bull Vet Inst Pulawy. 2009; 53: 187–192.
- Kubica-Biernat B., Kruminis-Lozowska W., Stanczak J., Cieniuch S. A study on the occurrence of West Nile virus in mosquitoes (Diptera: Culicidae) on the selected areas in Poland. Wiadomosci parazytologiczne 2009;55: 259-263.
- Niczyporuk JS, Samorek-Salamonowicz E, Mizak WK. The survey of wild birds for West Nile virus in Poland. Pol J Vet Sci. 2011; 14(4): 573–577.
- Niczyporuk JS. Niczyporuk JS, Wirus Zachodniego Nilu w Polsce - realne zagrożenie w świetle doniesień prezentowanych na konferencji "Aktualne problemy dotyczące czynników zakaźnych przenoszonych przez krew" Journal of Transfusion Medicine. 2017; 10: 54–62.
- Bażanów B, Jansen van Vuren P, Szymański P, et al. A Survey on West Nile and Usutu Viruses in Horses and Birds in Poland. Viruses. 2018; 10(2).
- Czupryna P, Niczyporuk J, Samorek-Salamonowicz E, et al. Poszukiwanie RNA wirusa zachodniego nilu w płynie mózgowordzeniowym u osób chorych na zapalenie opon mózgowordzeniowych z terenu województwa podlaskiego. Przegl Epidemiol. 2014; 68: 109.
- Tylewska-Wierzbanowska S. Kleszczowe zapalenie mózgu u dzieci i dorosłych. Forum Pediatrii. 2019; 5: 18–28.
- Stefanoff P, Rogalska J, Zajkowska J, Czerska M, Seroka W, Czarkowski MP. Surveillance of aseptic central nervous system infections in Poland: is itmeeting is it objectives? Euro Surveill 2011;16(29):pii:19924.
- Zajkowska J, Czupryna P. Kleszczowe zapalenie mózgu – epidemiologia, patogeneza, obraz kliniczny, diagnostyka, profilaktyka i leczenie. Forum zakażeń. 2013; 4(1): 21–27.
- Niczyporuk JS, Samorek-Salamonowicz E, Lecollinet S, et al. Occurrence of West Nile virus antibodies in wild birds, horses, and humans in Poland. Biomed Res Int. 2015; 2015: 234181.
- Pancewicz S. Moniuszko-Malinowska A., Zakażenia wybranymi wirusami z rodziny Flaviviridae, Wydanie I. Białystok: Uniwersytet Medyczny. ; 2017: 69–90.
- Jabłońska J, Popiel M, Bukowska-Ośko I, et al. No evidence of West Nile virus infection among Polish patients with encephalitis. Cent Eur J Immunol. 2016; 41(4): 383–385.
- Moniuszko-Malinowska A, Dunaj J, Czupryna P, et al. Absence of serological evidence for WNV presence in symptomatic patients in Poland. Infect Dis (Lond). 2019; 51(10): 782–784.
- Pealer LN, Marfin AA, Petersen LR, et al. West Nile Virus Transmission Investigation Team. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med. 2003; 349(13): 1236–1245.
- Stramer SL, Dodd RY. AABB Transfusion-Transmitted Diseases Emerging Infectious Diseases Subgroup. Transfusion-transmitted emerging infectious diseases: 30 years of challenges and progress. Transfusion. 2013; 53(10 Pt 2): 2375–2383.
- Tobler LH, Bianco C, Glynn SA, et al. NHLBI Retrovirus Epidemiology Study (REDS). Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic. Transfusion. 2005; 45(4): 480–486.
- Macedo de Oliveira A, Beecham BD, Montgomery SP, et al. West Nile virus blood transfusion-related infection despite nucleic acid testing. Transfusion. 2004; 44(12): 1695–1699.
- Lai L, Lee TH, Tobler L, et al. Relative distribution of West Nile virus RNA in blood compartments: implications for blood donor nucleic acid amplification technology screening. Transfusion. 2012; 52(2): 447–454.
- Mohr H, Knüver-Hopf J, Gravemann U, et al. West Nile virus in plasma is highly sensitive to methylene blue-light treatment. Transfusion. 2004; 44(6): 886–890.
- Williamson LM, Cardigan R, Prowse CV. Methylene blue-treated fresh-frozen plasma: what is its contribution to blood safety? Transfusion. 2003; 43(9): 1322–1329.
- Gallian P, Vignoli C, Dombey AM, et al. Inactivation of a European strain of West Nile virus in single- donor platelet concentrate using the INTERCEPT blood system. Vox Sang. 2006; 91(4): 345–347.
- Lin L, Hanson CV, Alter HJ, et al. Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light. Transfusion. 2005; 45(4): 580–590.
- Ruane PH, Edrich R, Gampp D, et al. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion. 2004; 44(6): 877–885.
- West Nile virus infection Annual Epidemiological Report for 2018] - https://www.ecdc.europa.eu/sites/default/files/documents/west-nile-fever-annual-epidemiological-report-2018.pdf.
- Weekly updates: 2019 West Nile virus transmission season - https://www.ecdc.europa.eu/en/west-nile-fever/surveillance-and-disease-data/disease-data-ecdc.
- West Nile Virus and Blood Safty Introduction to a Preparedness Plan in Europe. In: Prepared by: Greece I, Romania and France, ed. West Nile Virus and Blood Safty Introduction to a Preparedness Plan in Europe. Based on the EU Satellite Meeting of the Working Group on Blood Safety and WNV,Thessaloniki, 25-26 January. ; 2012: 2012.
- West Nile Virus and Blood Safety Introduction to a Preparedness Plan in Europe. In: West Nile Virus and Blood Safety Introduction to a Preparedness Plan in Europe. Based on the EU Satellite Meeting of the Working Group on Blood Safety and WNV T, 27 January 2011, ed. ; 2011.
- European Directorate for the Quality of Medicines and Health Care of the Council of Europe (EDQM), wyd. 18. ; 2020.
- Measures to ensure blood safety during the WNV season. w Meeting Report: Expert consultation on West Nile virus infection, Thessaloniki, 25–26 January 2011 [monograph on the internet]. European Centre for Disease Prevention and Control; 2011. http://ecdc.europa.eu/en/publications/Publications/1106_MER_WNV_Expert_Consultation.pdf.